Lawsuit asserting bad effects from the use of gadolinium contrast agents in MRI
Another case related to (alleged) bad effects from the use of gadolinium contrast agents in MRI, as for example to seek active
lesions in multiple sclerosis.
Case No.3:18-cv-491, in the United States District Court for the Western District of North Carolina.
For background, see the previous post on IPBiz
Linear gadolinium imaging agents and clear and convincing evidence
0 Comments:
Post a Comment
<< Home